Simcha Therapeutics Is A Clinical Stage Immunobiology Company Based In New Havenconnecticutfounded In 2018The Company Is Dedicated To Advancing Innovative Cancer Treatmentsfocusing On Engineered Cytokine Therapeutics To Meet The Needs Of Patients With Solid Tumors And Hematological Malignanciessimcha Operates With A Mission To Develop Transformative Therapies That Provide Hope To Cancer Patients The Company Is Currently Evaluating Its Lead Productst 067A Decoy Resistant Interleukin 18 Therapyin Multiple Clinical Trialsthese Include Phase 1 2 Trials For Solid Tumors And Newly Opened Studies For Acute Myeloid Leukemia And Multiple Myelomasimcha S Pipeline Emphasizes Il 18 Based Therapeuticswith A Recent License Agreement Aimed At Expanding Applications In Cell Therapiesthe Company Holds Patents For Il 18 Mimics And Related Methodsenhancing Its Position In The Oncology Field
No conferences found for this company.
| Company Name | Simcha Therapeutics |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
